MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 10-24-2023
NextGen Healthcare DPO Ratio 2011-2026 | NXGN
Annual DPO Ratio NextGen Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 14.5 | 14.4 | 8.04 | 6.37 | 7.55 | 18 | 16.4 | 13.1 | 22.1 | 10.9 | 19.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.1 | 6.37 | 13.7 |
Quarterly DPO Ratio NextGen Healthcare
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 | - | - | 6.86 | 2.56 | - | 17.2 | 12.5 | 5.83 | - | 9.5 | 10.4 | 13.1 | 13.3 | 9.54 | 7.15 | 7.83 | 6.33 | 7.29 | 6.93 | 5.48 | 5.36 | 7.32 | 9.18 | 7.42 | 7.59 | 8.95 | 8.03 | 12.4 | 17.2 | 18 | 18.7 | 17 | 13.8 | 13.4 | 14.9 | 13.4 | 10.3 | 8.75 | 4.45 | 9.03 | 15.4 | 9.96 | 21 | 16.8 | 11.9 | 14.2 | 14.9 | 16.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21 | 2.56 | 11.1 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
27 | $ 3.96 | 3.26 % | $ 371 M | USA |
 |
Akerna Corp.
KERN
|
89.4 | - | - | $ 161 M | USA |
 |
Health Catalyst
HCAT
|
19.9 | $ 2.26 | -4.45 % | $ 136 M | USA |
 |
HealthStream
HSTM
|
26.3 | $ 21.4 | -0.35 % | $ 650 M | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
47.8 | $ 84.41 | -2.33 % | $ 7.22 B | USA |
 |
Schrödinger
SDGR
|
66.5 | $ 16.47 | -4.96 % | $ 1.2 B | USA |
 |
American Well Corporation
AMWL
|
11.6 | $ 4.85 | -2.41 % | $ 72.7 M | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
10x Genomics
TXG
|
32.5 | $ 22.23 | -4.16 % | $ 2.6 B | USA |
 |
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 2.58 | 0.19 % | $ 995 M | USA |
 |
OptimizeRx Corporation
OPRX
|
24.1 | $ 11.92 | -0.33 % | $ 204 M | USA |
 |
Omnicell
OMCL
|
27.6 | $ 50.44 | -1.71 % | $ 2.32 B | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
Progyny
PGNY
|
171 | $ 25.34 | 1.34 % | $ 2.17 B | USA |
 |
Phreesia
PHR
|
57.8 | $ 15.83 | 0.22 % | $ 864 M | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
32 | $ 0.44 | -3.68 % | $ 2.29 M |  China |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
18.6 | $ 6.26 | -1.5 % | $ 1.07 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
19.7 | $ 222.54 | -1.21 % | $ 35.7 B | USA |
 |
SCWorx Corp.
WORX
|
43.2 | $ 0.25 | 35.29 % | $ 365 K | USA |